Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas

Abstract

The gene defect for hereditary papillary renal carcinoma1 (HPRC) has recently been mapped to chromosome 7q, and germline mutations of MET (also known as c-met) at 7q31 have been detected in patients with HPRC (ref. 2). Tumours from these patients commonly show trisomy of chromosome 7 when analysed by cytogenetic studies and comparative genomic hybridization3 (CGH). However, the relationship between trisomy 7 and MET germline mutations is not clear. We studied 16 renal tumours from two patients with documented germline mutations in exon 16 of MET. Flourescent in situ hybridization (FISH) analysis showed trisomy 7 in all tumours. To determine whether the chromosome bearing the mutant or wild-type MET gene was duplicated, we performed duplex PCR and phosphoimage densitometry using polymorphic microsatellite markers D7S1801 and D7S1822, which were linked to the disease gene locus, and D1S1646 as an internal control. We determined the parental origin of chromosome alleles by genotyping parental DNA. In all 16 tumours there was an increased signal intensity (2:1 ratio) of the microsatellite allele from the chromosome bearing the mutant MET compared with the allele from the chromosome bearing the wild-type MET. Our study demonstrates a non-random duplication of the chromosome bearing the mutated MET in HPRC and implicates this event in tumorigenesis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: FISH analysis of lymphoblastoid cell line and tumour tissues from HPRC patients.
Figure 2: Genotyping, quantitative duplex PCR amplification and sequencing analysis of normal and tumour samples in patient 1.
Figure 3: Clonality analysis of 10 different tumours from a female patient (patient 1).
Figure 4: Quantitive PCR amplification of normal kidney and tumour tissues to analyse allelic imbalance of chromsome 17 from patient 2.

Similar content being viewed by others

References

  1. Zbar, B. et al. Hereditary papillary renal carcinoma. J. Urol. 153, 907–912 (1995).

    Article  CAS  Google Scholar 

  2. Schmidt, L. et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nature Genet. 16, 68–73 ( 1997).

    Article  CAS  Google Scholar 

  3. Kovacs, G. Molecular cytogenetics of renal tumours. Adv. Cancer Res. 62, 89–124 (1993).

    Article  CAS  Google Scholar 

  4. Schmidt, L. et al. Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene. Cancer Res. 58, 1719–1722 (1998).

    CAS  PubMed  Google Scholar 

  5. Rowley, J.D. Biological implications of consistent chromosome rearrangements in leukemia and lymphoma. Cancer Res. 44, 3159– 3168 (1984).

    CAS  PubMed  Google Scholar 

  6. Bianchi, A.B., Aldaz, C.M. & Conti, C.J. Nonrandom duplication of the chromosome bearing a mutated Ha-ras-1 allele in mouse skin tumours. Proc. Natl Acad. Sci. USA 87, 6902-6906 ( 1990).

    Article  CAS  Google Scholar 

  7. Bremner, R. & Balmain, A. Genetic changes in skin tumour progression: correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7. Cell 61, 407– 417 (1990).

    Article  CAS  Google Scholar 

  8. Wirschubsky, Z., Wiener, F., Spira, J., Sümegi, J. & Klein, G. Triplication of one chromosome no. 15 with an altered c-myc containing EcoRI fragment and elimination of the normal homologue in a T-cell lymphoma line of AKR origin (TIKAUT). Int. J. Cancer 33, 477–481 ( 1984).

    Article  CAS  Google Scholar 

  9. Jeffers, M. et al. Activating mutations for the MET tyrosine kinase receptor in human cancer. Proc. Natl Acad. Sci. USA 94, 11445–11450 (1997).

    Article  CAS  Google Scholar 

  10. Knudson, A.G. Genetics of human cancer. Ann. Rev. Genet. 20, 231–251 (1986).

    Article  Google Scholar 

  11. Pinkel, D. et al. Fluorescence in situ hybridization with human chromosome-specific libraries: detection of the trisomy 21 and translocations of chromosome 4. Proc. Natl Acad. Sci. USA 85, 9138– 914 (1988).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhengping Zhuang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhuang, Z., Park, WS., Pack, S. et al. Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas. Nat Genet 20, 66–69 (1998). https://doi.org/10.1038/1727

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/1727

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing